SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IVAX, Generic Giant
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Doug who wrote (143)4/2/1997 11:08:00 PM
From: MD Payne   of 212
 
Doug,

I was unable to reach I. R. today. I had the expectation to a similar degree of a forthcoming Ivax comment and from a P. R. point it would seem in the best interest for shareholders. Regarding insider ownership, the most recent I can find is a 10-405K filed on 3/31/97 @ Edgar - - - - - - -
sec.gov
Make sure you read all the footnotes. The indication is All directors and Executive Officers as a group own 22,177,760 shares or 18.2% before a deduction by my math of 1,308,713 shares or 1.07% equals the aggregate Shares Which May Acquired Pursuant to Exercisable Options Within Sixty (60) Days of March 20, 1997 (Could Be An Interesting Timeframe?). Further, the latest short interest info I have seen was a recent post by . . . . . harkenman (See #134).

I hope this helps.

Thanks
mdp

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News